Form 4 for INSM INSMED Inc
Accepted 2025-01-16 00:00:00 ET · period of report 2025-01-15 · accession 0001628280-25-001732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $70.17 | -6,830 | 239.3K | -3% | -$479.3K |
| DI | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DM | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $70.18 | -31.8K | 382.0K | -8% | -$2.23M |
| D | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 411.3K | +5% | +$426.8K |
| DI | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -6,830 | 218.6K | -3% | $0 |
| D | 2025-01-16 | 2025-01-15 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -18.8K | 75.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | S | D | 631 | $71.01 | 233,924 | I | — | — | (F7) This is the weighted average sales price representing 631 shares sold at prices ranging from $70.92 to $71.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2025-01-15 | S | D | 4,700 | $70.31 | 234,555 | I | — | — | (F6) This is the weighted average sales price representing 4,700 shares sold at prices ranging from $69.91 to $70.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2025-01-15 | S | D | 1,499 | $69.40 | 239,255 | I | — | — | (F5) This is the weighted average sales price representing 1,499 shares sold at prices ranging from $68.87 to $69.87 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2025-01-15 | M | A | 6,830 | $10.85 | 240,754 | I | — | — | |
| 5 | Common | Common Stock | 2025-01-15 | S | D | 2,473 | $71.05 | 379,534 | D By the Katie Procter Dynasty Trust | — | — | (F4) This is the weighted average sales price representing 2,473 shares sold at prices ranging from $70.89 to $71.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 6 | Common | Common Stock | 2025-01-15 | S | D | 6,636 | $69.39 | 404,703 | D By the Katie Procter Dynasty Trust | — | — | (F2) This is the weighted average sales price representing 6,636 shares sold at prices ranging from $68.87 to $69.86 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Common | Common Stock | 2025-01-15 | M | A | 18,750 | $22.76 | 411,339 | D By the Katie Procter Dynasty Trust | — | — | |
| 8 | Common | Common Stock | 2025-01-15 | S | D | 22,696 | $70.32 | 382,007 | D By the Katie Procter Dynasty Trust | — | — | (F3) This is the weighted average sales price representing 22,696 shares sold at prices ranging from $69.89 to $70.89 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 9 | Derivative | Stock Option (right to buy) | 2025-01-15 | M | D | 6,830 | $0.00 | 218,630 | I | $10.85 · — to 2026-05-19 | 6,830 Common Stock | (F8) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 10 | Derivative | Stock Option (right to buy) | 2025-01-15 | M | D | 18,750 | $0.00 | 75,000 | D By the Katie Procter Dynasty Trust | $22.76 · — to 2025-05-21 | 18,750 Common Stock | (F8) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |